Market Overview

Bristol-Myers Squibb Company Announces Final Results of Exchange Offers for Celgene Corporation Notes

Share:

Bristol-Myers Squibb Company (NYSE:BMY) ("Bristol-Myers Squibb") announced today the final results of the offers to exchange (the "Exchange Offers") notes (the "Celgene Notes") issued by Celgene Corporation (NASDAQ:CELG) ("Celgene") for up to $19,850,000,000 aggregate principal amount of new notes to be issued by Bristol-Myers Squibb Company (the "Bristol-Myers Squibb Notes") and cash and the related consent solicitations (the "Consent Solicitations") made by Bristol-Myers Squibb on behalf of Celgene to adopt certain proposed amendments (the "Amendments") to the indentures governing the Celgene Notes. The Exchange Offers and Consent Solicitations expired at 5:00 p.m., New York City time, on November 20, 2019 (the "Expiration Date").

As of the Expiration Date, an aggregate of $18.5 billion principal amount of Celgene Notes had been validly tendered and not validly withdrawn as set forth in the table below:

Title of Series

 

CUSIP Number

 

Aggregate

Principal

Amount

Outstanding

Celgene Notes Tendered as of

5:00 p.m., New York City time,

on November 20, 2019

   

Principal Amount

Percentage

2.875% Senior Notes due 2020

 

151020 AQ7

 

$

1,500,000,000

$

1,243,777,000

82.92

%

3.950% Senior Notes due 2020

 

151020 AE4

 

$

500,000,000

$

436,313,000

87.26

%

2.875% Senior Notes due 2021

 

151020 BC7

 

$

500,000,000

$

434,815,000

86.96

%

2.250% Senior Notes due 2021

 

151020 AV6

 

$

500,000,000

$

464,576,000

92.92

%

3.250% Senior Notes due 2022

 

151020 AH7

 

$

1,000,000,000

$

861,709,000

86.17

%

3.550% Senior Notes due 2022

 

151020 AR5

 

$

1,000,000,000

$

891,870,000

89.19

%

2.750% Senior Notes due 2023

 

151020 AX2

 

$

750,000,000

$

697,660,000

93.02

%

3.250% Senior Notes due 2023

 

151020 BA1

 

$

1,000,000,000

$

932,101,000

93.21

%

4.000% Senior Notes due 2023

 

151020 AJ3

 

$

700,000,000

$

636,086,000

90.87

%

3.625% Senior Notes due 2024

 

151020 AP9

 

$

1,000,000,000

$

882,510,000

88.25

%

3.875% Senior Notes due 2025

 

151020 AS3

 

$

2,500,000,000

$

2,379,532,000

95.18

%

3.450% Senior Notes due 2027

 

151020 AY0

 

$

1,000,000,000

$

961,528,000

96.15

%

3.900% Senior Notes due 2028

 

151020 BB9

 

$

1,500,000,000

$

1,456,162,000

97.08

%

5.700% Senior Notes due 2040

 

151020 AF1

 

$

250,000,000

$

245,785,000

98.31

%

5.250% Senior Notes due 2043

 

151020 AL8

 

$

400,000,000

$

391,925,000

97.98

%

4.625% Senior Notes due 2044

 

151020 AM6

 

$

1,000,000,000

$

976,477,000

97.65

%

5.000% Senior Notes due 2045

 

151020 AU8

 

$

2,000,000,000

$

1,959,524,000

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com